Serum folate and risk of fatal coronary heart disease

JAMA

Volumn 275, Issue 24, 1996, Pages 1893-1896

  Morrison, Howard I ^a,b   Schaubel, Douglas ^a   Desmeules, Marie ^a   Wigle, Donald T ^a  

^a HEALTH CANADA   (Canada)

^b LAB CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CORONARY RISK; DIETARY INTAKE; FATALITY; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0029938206     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.275.24.1893     Document Type: Article

References (33)

1. Semenciw R, Morrison H, Mao Y, Johansen H, Davies JW, Wigle D. Major risk factors for cardiovascular disease mortality in adults: results from the Nutrition Canada Survey, Int J Epidemiol. 1988;17:317-324.
2. Kannel B. An overview of the risk factors for cardiovascular disease. In: Kaplan N, Stamler J, eds. Prevention of Coronary Heart Disease. Philadelphia, Pa: WB Saunders Co; 1983:1-19.
3. Martin M. Browner WS, Wentworth D, Hulley SB, Kuller LH. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361662 men. Lancet. 1986;2:923-926.
4. Pancharuniti N, LewisCA, Sauherlich HE, et al. Plasma homocysteine, folate, and vitamin B-12 concentrations and risk for early onset coronary artery disease. Am J Clin Nutr. 1994;59:940-948.
5. Selhub J, Jacques PF, Bostom AG, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med. 1995;332:286-291.
6. Stampfer MJ, Malinow MR. Can lowering homocysteine levels reduce cardiovascular risk? N Engl J Med. 1995;332:328-329.
7. Ueland PM, Refsum H, Brattström L. Plasma homocysteine and cardiovascular disease. In: Francis RB Jr, ed. Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Function. New York, NY: Marcel Dekker Inc; 1992:183-236.
8. Kang S, Wong PW, Malinow MR. Hyperhomoeysteinemia as a risk factor for occlusive vascular disease. Annu Rev Nutr. 1992;12:279-298.
9. Gaby SK, Bendich A. Folic acid. In: Gaby SK, Bendich A, Singh VN, et al, eds. Vitamin Intake and Health: A Scientific Review. New York, NY: Marcel Dekker Inc; 1991.
10. Kang SS, Wong PW, Norusis M. Homocysteinemia due to folate deficiency. Metabolism. 1987;36: 458-462.
11. Department of National Health and Welfare. Nutrition Canada National Survey. Ottawa, Ontario: Information Canada; 1973. Catalog No. H58-36/1973.
12. Johansen H, Semenciw R, Morrison HI, et al. Important risk factors for adult mortality: a ten year follow-up of the Nutrition Canada Survey cohort. Can Med Assoc J. 1987;136:823-828.
13. Watt BK, Merrill AL. Composition of Foods. Washington, DC: Agricultural Research Service, US Dept of Agriculture; 1963. Agricultural Handbook No. 8.
14. Department of National Health and Welfare. Nutrition Canada Food Consumption Patterns Report, Ottawa, Ontario: Information Canada; 1973. Catalog No. H58-36/1973.
15. Howe G, Lindsay J. A generalized iterative record linkage computer system for use in medical follow-up studies. Comput Biomed Res. 1981;14: 327-340.
16. National Center for Health Statistics. International Classification of Diseases, Adapted for Use in the United States. 8th rev. Washington, DC: US Dept of Health, Education, and Welfare, Public Health Service; 1967.
17. Shannon HS, Jamieson E, Walsh C, Julian JA, Fair ME, Buffet A. Comparison of individual follow-up and computerized linkage using the Canadian Mortality Data Base. Can J Public Health. 1989; 80:54-57.
18. Aronow WS, Ahn C, Sehonenfeld M, Gutstein H. Extracranial carotid arterial disease: a prognostic factor for atherothrombotic brain infarction and cerebral transient ischemic attack. N Y State J Med. 1992;92:424-425.
19. O'Leary DH, Polak JF, Kronmal RA, et al. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. Stroke. 1992;23:1752-1760.
20. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 1991;11; 1245-1249.
21. Aronow WS, Sehonenfeld MR. Forty-five month follow-up of extracranial carotid arterial disease for new coronary events in elderly patients. Coron Artery Dis. 1992;3:249-251.
22. Mojonnier L, Hall Y. The National Diet Heart Study - assessment of dietary adherence. J Am Diet Assoc. 1968;52:288-292.
23. MRC Vitamin Study Research Group. Prevention of neural tube defects: results from the Medical Research Council Vitamin Study. Lancet. 1991;338: 131-137.
24. Butterworth CE Jr, Hatch KD, Macaluso M, et al. Folate deficiency and cervical dysplasia. JAMA 1992;267:528-533.
25. Freudenheim JL, Graham S, Marshall JR, Haughey BP, Cholewinski S, Wilkinson G. Folate intake and carcinogenesis of the colon and rectum. Int J Epidemiol. 1991;20:368-374.
26. Block G. Micronutrients and cancer: time for action? J Natl Cancer Inst. 1993;85:846-848.
27. Romano PS, Waitzman NJ, Scheffler RM, Pi RD. Folic acid fortification of grain: an economic analysis. Am J Public Health. 1995;85:667-676.
28. Chanarin I. Adverse effects of increased dietary folate: relation to measures to reduce the incidence of neural tube defects. Clin Invest Med. 1994;17253-255.
29. Bayless EM, Crowley JM, Preece JM, et al. Influence of folic acid on blood phenytoin levels. Lancet. 1971;1:62-64.
30. National Research Council. Recommended Dietary Allowances, 10th ed. Washington, DC: National Academy Press; 1989.
31. Subar AF, Block G, James LD. Folate intake and food sources in the US population. Am J Clin Nutr. 1989;50:508-516.
32. Sauberlich HE, Dretsch MJ, Skala JH, Johnson HL, Taylor PC. Folate requirement and metabolism in nonpregnant women. Am J Clin Nutr. 1987; 46:1016-1028.
33. Foulke J. Folic acid to fortify U.S. food products to prevent birth defects. Food and Drug Administration press release, February 29, 1996.